Skip to content

The generic generation

Efavirenz and the brain: are we nearer to solving a mysterious side-effect?

Huge differences in HIV mortality rates in US according to race, social and economic status

High-dose multivitamins have no benefit for people starting HIV treatment but cause serious liver disturbances

CNS symptoms common in people taking raltegravir

Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Dosing frequency and number of pills don't affect HIV treatment outcomes

Higher levels of adherence to hepatitis C therapy improve treatment outcomes in people with hepatitis C and HIV

From today, HIV treatment is free for all who need it in England